Monday, January 24, 2022

Dr.Reddy's

Dr Reddy’s launches Mintop for hair loss treatment

Hyderabad: Dr Reddy’s Laboratories launched the prescription drug Minoxidil topical solution USP 2 per cent and 5 per cent for the treatment of female...

Dr Reddy’s enters into definitive agreement with Citius Pharmaceuticals

Under the terms of agreement, Dr Reddy’s will receive $40 million upfront upon the closing of the transaction, followed by approval milestone payment of up to $40 million related to the CTCL (cutaneous T-cell lymphoma)

Dr Reddy’s launches generic stomach ulcer drug in US

Hyderabad: Hyderabad-based Dr Reddy's Laboratories launched generic Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules in the US market, used for treatment of stomach ulcers, irritable...

Equities on tenterhooks: Covid concerns, Fed decision to induce caution

In addition, Vinod Nair, Head of Research at Geojit Financial Services said the upcoming week will be driven by global sentiments.

Dr Reddy’s to strengthen commercial roll-out of Sputnik V in coming weeks

Soft launch of Sputnik V vaccine reaches over 50 cities and towns, after initial launch in Hyderabad on May 14

Expert panel permits Dr Reddy’s to submit Sputnik Light Russian phase III data in India

On Wednesday, the Subject Expert Committee (SEC) deliberated on the submission for Marketing Authorisation of Sputnik Light in India from Dr Reddy’s

Dr Reddy’s collaborates with four pharma companies for molnupiravir trial

On successful completion of the clinical trial, each company will independently approach the regulatory authorities for approval to manufacture and supply the drug for the treatment of Covid-19 in India

Dr Reddy’s in final phase of Sputnik V pilot rollout

Being a limited pilot phase presently, registration on CoWIN is not open yet to public, but will become open at the time of commercial launch.

Dr Reddy’s recalls 2,980 bottles of cholesterol lowering drug

The Hyderabad-based drug major is voluntarily recalling the affected lots of the drug in 10 mg strength due to “failed impurities degradation specifications”.

Snowman Logistics, Dr Reddy’s partner for Sputnik V vaccine

"With this partnership with Dr Reddy’s, we aim to reach maximum institutions administering vaccines through our five high-capacity temperature-controlled warehouses," said Sunil Nair, CEO, Snowman Logistics.

Legal action initiated against fraudsters, say Dr Reddy’s-RDIF

Hyderabad firm says it will not take responsibility for the consequences of unauthorised deals, fraudulent financial transactions or sub-standard products resulting from fraud in the name of Sputnik V vaccine

Dr Reddy’s lines up Rs 1,000 cr capex for current fiscal

The drug maker's growth would be primarily driven by organic moves, focusing around pipeline monetisation, productivity enhancement, diversifications.

Dr Reddy’s developing new treatment options for COVID-19, says MD

The drug firm over the past few weeks has ramped up supply of multiple medicines including Remdesivir to meet the surge in demand.

Apollo Hospitals partners with Dr Reddy’s to administer Sputnik V vaccines

Pilot programme to administer from the first batch of 1,50,000 doses of Sputnik V vaccines imported from RDIF

Dr Reddy’s Laboratories gearing up with Covid portfolio

Plan to vaccinate 125 million people in the next 8-12 months across the country

Latest News

- Advertisement -